Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways - Resistance to Targeted Anti-Cancer Therapeutics -  - Livros - Springer Nature Switzerland AG - 9783030098179 - 2 de fevereiro de 2019
Caso a capa e o título não sejam correspondentes, considere o título como correto

Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways - Resistance to Targeted Anti-Cancer Therapeutics Softcover Reprint of the Original 1st 2018 edition

Preço
R$ 841,90
excluindo impostos

Item sob encomenda (no estoque do fornecedor)

Espera-se estar pronto para envio 5 - 9 de out
Adicione à sua lista de desejos do iMusic

Ainda não avaliado

This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression.


242 pages, 22 Illustrations, color; XX, 242 p. 22 illus. in color.

Mídia Livros     Paperback Book   (Livro de capa flexível e brochura)
Lançado 2 de fevereiro de 2019
ISBN13 9783030098179
Editoras Springer Nature Switzerland AG
Páginas 242
Dimensões 150 × 220 × 10 mm   ·   406 g
Idioma Alemão  
Editor Elkabets, Moshe
Editor Yarden, Yosef

Mais da mesma editora